Intraocular pressure and cardiovascular effects of dexmedetomidine premedication and tiletamine-zolazepam for anesthetic induction in dogs

Abstract

Background and Aim: The effect of anesthetic drugs on intraocular pressure (IOP) is an important concern in ophthalmic surgery. The impact of dexmedetomidine (DEX) combined with tiletamine-zolazepam on IOP is scarcely studied. This study aimed to evaluate IOP and cardiovascular effects in dogs after premedication with 5 μg/kg (DEX5) or 10 μg/kg (DEX10) of intramuscular DEX followed by intravenous tiletamine-zolazepam administration for induction of anesthesia in healthy dogs. Materials and Methods: Eighteen dogs, American Society of Anesthesiologists I or II, without ocular abnormality were investigated. All dogs were randomly divided into the DEX5 (n = 9) and DEX10 groups (n = 9). The IOP, heart rate (HR), systolic blood pressure (SBP), oxygen saturation, and sedation scale were measured before premedication (baseline), after premedication at 5, 10, 15, and 20 min, after tiletamine-zolazepam administration, after endotracheal intubation, and post-operative. Results: There were no significant differences between the groups at any time point. The DEX5 and DEX10 groups had significantly decreased HR values at 10 min compared with baseline. The IOP at 20 min was significantly lower compared to the baseline in the DEX10 group. Moreover, the DEX10 group showed increased IOP, HR, SBP, and sedation scale values after induction and intubation compared with 20 min, but these values did not differ significantly from baseline. All parameters of both groups did not change significantly between post-operative and baseline. Conclusion: Intramuscular DEX (10 μg/kg) is an appropriate premedication in ophthalmic examination or surgical procedures. Moreover, it could be combined with tiletamine-zolazepam for generalized anesthesia in dogs with an ophthalmic problem, as it had no clinically significant effects on IOP or cardiovascular values.

Effects of intramuscular alfaxalone and dexmedetomidine alone and combined on ocular, electroretinographic, and cardiorespiratory parameters in normal cats

“…Wolfran et al reported that IM administration of dexmedetomidine (10 μg/kg) reduced IOP and tear production in cats, while a lower dose of 7.5 μg/kg had no significant effect on IOP ( 36 ). In dogs receiving intravenous injection of 5 μg/kg dexmedetomidine, there was no significant difference in IOP measurements within 10 min of drug administration ( 37 , 38 ). Cats sedation with intramuscular 100 μg/kg medetomidine did not cause a statistically significant change in IOP values ( 14 ).…”